iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025)
iSpecimen (ISPC) recorded quarterly Cash from Financing Activities of $5.0 million in Q4 2025, down 4.1% quarter-over-quarter from $5.2 million in Q3 2025, and up 32.94% on a YoY basis from $3.8 million in Q4 2024.
iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025) Analysis & Trends
iSpecimen's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $5.0 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 32.94% year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $14.9 million (up 155.66% YoY), while the FY2025 annual figure was $10.2 million, up 76.04% from the prior year.
- Cash from Financing Activities was $5.0 million for Q4 2025 at iSpecimen, down from $5.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $19.6 million in Q4 2021 to a low of -$3.5 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged $2.5 million across 5 years, with a median of $467628.5 in 2022.
- Biggest YoY gain for Cash from Financing Activities was 41304.5% in 2024; the steepest drop was 275.47% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $19.6 million in 2021, then slumped by 117.88% to -$3.5 million in 2022, then surged by 100.09% to $3153.0 in 2023, then jumped by 119541.45% to $3.8 million in 2024, then surged by 32.94% to $5.0 million in 2025.
- The last three Cash from Financing Activities figures came in at $5.0 million (Q4 2025), $5.2 million (Q3 2025), and $3.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 859,980.00 |
| Sep 30, 2024 | 859,980.00 |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | -118,858.00 |
| Mar 31, 2024 | -118,858.00 |
| Jun 30, 2023 | 3,153.00 |
| Jun 30, 2023 | 3,153.00 |
| Mar 31, 2023 | 67,736.00 |
| Mar 31, 2023 | 67,736.00 |
| Dec 31, 2022 | -3.50 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | -4,967.00 |
| Sep 30, 2022 | -4,967.00 |